Array Technologies (ARRY)
(Delayed Data from NSDQ)
$12.98 USD
-0.15 (-1.14%)
Updated Jun 13, 2024 04:00 PM ET
After-Market: $12.96 -0.02 (-0.15%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Brokerage Reports
0 items in cart
Array Technologies, Inc. [ARRY]
Reports for Purchase
Showing records 521 - 540 ( 549 total )
Company: Array Technologies, Inc.
Industry: Solar
Initiating at Buy on Strong Growth and Industry Position
Provider: Roth Capital Partners, Inc.
Analyst: SHEN P
Company: Array Technologies, Inc.
Industry: Solar
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
We are placing Array BioPharma Under Review due to the departure from the firm of analyst, Simos Simeonidis
Provider: RODMAN & RENSHAW, CO.
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
We are placing Array BioPharma Under Review due to the departure from the firm of analyst, Simos Simeonidis
Provider: RODMAN & RENSHAW, CO.
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Reports 2Q11 numbers; waiting for selumetinib (MEK inhibitor) data this year
Provider: RODMAN & RENSHAW, CO.
Analyst: SIMEONIDIS S
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Reports 2Q11 numbers; waiting for selumetinib (MEK inhibitor) data this year
Provider: RODMAN & RENSHAW, CO.
Analyst: SIMEONIDIS S
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
KSP inhibitor looks good in heavily pretreated Multiple Myeloma patients
Provider: RODMAN & RENSHAW, CO.
Analyst: SIMEONIDIS S
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.